Technetium TC-99M trofolastat
Star0
Explore a selection of our essential drug information below, or:
Overview
- DrugBank ID
- DB18803
- Type
- Small Molecule
- Clinical Trials
- Phase 0
- 0
- Phase 1
- 3
- Phase 2
- 1
- Phase 3
- 1
- Phase 4
- 0
Identification
- Generic Name
- Technetium TC-99M trofolastat
- DrugBank Accession Number
- DB18803
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 1134.769
Monoisotopic: 1134.187258788 - Chemical Formula
- C40H47N10O23Tc
- Synonyms
- (oc-6-33)-tricarbonyl(n2-(((1s)-1,3-dicarboxypropyl)carbamoyl)-l-.gamma.-glutamyl-n6,n6-bis((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1h-imidazol-2-yl-.kappa.n3)methyl)-l-lysine-.kappa.n6)(99mtc)technetium(+)
- 99mTc-MIP-1404
- Technetium tc-99m trofolastat cation
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- W23EFJ3KDD
- CAS number
- 1333204-77-5
- InChI Key
- RQPDXUDTXCPYGU-OIOJJZKLSA-K
- InChI
- InChI=1S/C37H50N10O20.3CO.Tc/c48-26(6-4-22(35(63)64)41-37(67)42-23(36(65)66)5-7-29(51)52)40-21(34(61)62)3-1-2-10-43(13-24-38-8-11-44(24)15-27(49)46(17-30(53)54)18-31(55)56)14-25-39-9-12-45(25)16-28(50)47(19-32(57)58)20-33(59)60;3*1-2;/h8-9,11-12,21-23H,1-7,10,13-20H2,(H,40,48)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66)(H2,41,42,67);;;;/q;;;;+4/p-3/t21-,22-,23-;;;;/m0..../s1/i;;;;1+1
- IUPAC Name
- SMILES
- [H+].[H+].[H+].[H+].[H+].[99Tc+4].[C-]#[O+].[C-]#[O+].[C-]#[O+].[O-]C(=O)CC[C@H](NC(=O)N[C@@H](CCC(=O)N[C@@H](CCCCN(CC1=NC=CN1CC(=O)N(CC([O-])=O)CC([O-])=O)CC1=NC=CN1CC(=O)N(CC([O-])=O)CC([O-])=O)C([O-])=O)C([O-])=O)C([O-])=O
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data3 Completed Diagnostic Prostate Cancer 1 somestatus stop reason just information to hide 2 Completed Diagnostic Prostate Cancer 1 somestatus stop reason just information to hide 1 Completed Diagnostic Prostate Cancer 3 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 21, 2024 19:33 / Updated at November 05, 2024 05:15